You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (3) |
Back to Search
Genomewide approaches to discovering drug safety biomarkers
- In: Symposium E1: Clinical Implementation of Precision Medicine: From genomewide discovery to practice on Monday, 22 May 2017, 15:00-15:10
- At: Stockholm (Sweden) (2017)
- Type: Presentation
- By: PIRMOHAMED, Munir (University Of Liverpool, Molecular And Clinical Pharmacology, Liverpool, United Kingdom)
- Co-author(s): Professor Sir Munir HUSSEIN PIRMOHAMED: Molecular And Clinical Pharmacology, University Of Liverpool, Liverpool, United Kingdom
- Abstract:
Adverse drug reactions (ADRs) are a major clinical problem accounting for a great deal of morbidity, mortality and are a drain on healthcare resources. ADRs can generally be divided into on-target and off target reactions. Both types of ADRs have a genetic predisposition, but the quantitative contribution of genetic vs. non-genetic factors
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026